While it fosters hepatic immune tolerance and induces CD8+ T cell dysfunction in the precancerous stage, its enhanced expression during chronic HBV infection might favor tumor growth by curbing the anti-tumor responses of effector T cells [75]. Here, CD8A is linked to neoplasm.